Journal articles: 'Circulatory death'

1

Manara, A. R., P. G. Murphy, and G. O’Callaghan. "Donation after circulatory death." British Journal of Anaesthesia 108 (January 2012): i108—i121. http://dx.doi.org/10.1093/bja/aer357.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Patel, Sameer, Jonathan R. Martin, and Philip S. Marino. "Donation After Circulatory Death." Critical Care Medicine 42, no. 10 (October 2014): 2219–24. http://dx.doi.org/10.1097/ccm.0000000000000511.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Dunne, Kathryn, and Pamela Doherty. "Donation after circulatory death." Continuing Education in Anaesthesia Critical Care & Pain 11, no. 3 (June 2011): 82–86. http://dx.doi.org/10.1093/bjaceaccp/mkr003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

del Mar Lomero, Maria, Rachel Johnson, Elisabeth Coll, Nichon Jansen, Corinne Antoine, Francesco Procaccio, Nessa Lynch, et al. "Donation after Circulatory Death." Transplantation 102 (July 2018): S386. http://dx.doi.org/10.1097/01.tp.0000543149.04890.0a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Gysin, Dorene M., Toufic S. Khairallah, and Michelle Reef. "Donation after circulatory death." OR Nurse 9, no. 2 (March 2015): 28–36. http://dx.doi.org/10.1097/01.orn.0000460899.56189.b2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

&NA;. "Donation after circulatory death." OR Nurse 9, no. 2 (March 2015): 36–37. http://dx.doi.org/10.1097/01.orn.0000462051.81201.fe.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Sque, Magi, and Wendy M. Walker. "Donation After Circulatory Death." Transplantation 101 (August 2017): S22. http://dx.doi.org/10.1097/01.tp.0000525004.20743.fa.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Algahim, Mohamed F., and Robert B. Love. "Donation after circulatory death." Current Opinion in Organ Transplantation 20, no. 2 (April 2015): 127–32. http://dx.doi.org/10.1097/mot.0000000000000179.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Morrissey, Paul E., and Anthony P. Monaco. "Donation After Circulatory Death." Transplantation Journal 97, no. 3 (February 2014): 258–64. http://dx.doi.org/10.1097/01.tp.0000437178.48174.db.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hatamzade, E. M. "Features of monthly and seasonal dynamics of mortality risk from circulatory system diseases in Sumgait." Kazan medical journal 97, no. 2 (April 15, 2016): 279–82. http://dx.doi.org/10.17750/kmj2016-279.

Full text

Abstract:

Aim. The aim of the study was to evaluate the population mortality seasonal dynamics in the settings of emergency medical care availability.Methods. The study was conducted in Sumgait based on the medical certificates of death data analysis for 2013. The average daily number of deaths from all causes and from circulatory system diseases, the monthly number of death cases proportion in the structure of annual death cases, the proportion of deaths from circulatory system diseases among the total number of deaths were calculated.Results. The average daily number of deaths from all causes was 4.42, including 2.72 cases - from circulatory system diseases. The average daily number of death cases from all causes below the annual average rate was observed in June, July, August and September, and when performing the seasonal analysis - in summer and autumn; from circulatory system diseases - in January, June, September and December. The winter and spring increase in all-cause mortality rate was registered, whereas the mortality rate peak was characteristic for February and March. In the seasonality analysis the largest proportion of death cases number from circulatory system diseases in the structure of total annual mortality rate was in the spring. The proportion of deaths from circulatory diseases among the death causes of Sumgait population was 61.5±1.2%. In winter, the proportion of deaths from circulatory system diseases in the structure of causes of death from all causes was minimal (53.3±2.3%), and in the summer - the maximum (68.9±2.4%).Conclusion. The regularity of mortality seasonal dynamics in Sumgait is the winter-spring increase and summer decrease in all-cause mortality rate; distinctive feature of the mortality seasonal dynamics in Sumgait is associated with mortality risk increase in spring due to circulatory system diseases.

APA, Harvard, Vancouver, ISO, and other styles

11

Blackstock, Murray J., and David C. Ray. "Organ donation after circulatory death." European Journal of Emergency Medicine 21, no. 5 (October 2014): 324–29. http://dx.doi.org/10.1097/mej.0000000000000082.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Jericho, Barbara G. "Organ Donation After Circulatory Death." Anesthesia & Analgesia 128, no. 2 (February 2019): 280–85. http://dx.doi.org/10.1213/ane.0000000000003448.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Ceulemans, Laurens J., Ilhan Inci, and Dirk Van Raemdonck. "Lung donation after circulatory death." Current Opinion in Organ Transplantation 24, no. 3 (June 2019): 288–96. http://dx.doi.org/10.1097/mot.0000000000000627.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Molina, María, Beatriz Domínguez-Gil, José M. Pérez-Villares, and Amado Andrés. "Uncontrolled donation after circulatory death." Current Opinion in Organ Transplantation 24, no. 3 (June 2019): 358–63. http://dx.doi.org/10.1097/mot.0000000000000648.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Iyer, Arjun, and Kumud Dhital. "Cardiac donation after circulatory death." Current Opinion in Organ Transplantation 25, no. 3 (June 2020): 241–47. http://dx.doi.org/10.1097/mot.0000000000000758.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Bramstedt, Katrina A. "Organ Donation After Circulatory Death." JAMA 314, no. 15 (October 20, 2015): 1646. http://dx.doi.org/10.1001/jama.2015.11414.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Weiss, Elliott M., and Kathryn E. Miller. "Organ Donation After Circulatory Death." JAMA 314, no. 15 (October 20, 2015): 1645. http://dx.doi.org/10.1001/jama.2015.11432.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

McGee, Andrew, Dale Gardiner, and Paul Murphy. "Determination of death in donation after circulatory death." Current Opinion in Organ Transplantation 23, no. 1 (February 2018): 114–19. http://dx.doi.org/10.1097/mot.0000000000000478.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Salim, Thais Rocha, Gabriel Porto Soares, Carlos Henrique Klein, and Gláucia Maria Moraes Oliveira. "Fetal and maternal factors are associated with mortality due to circulatory system disorders in children." Revista de Saúde Pública 53 (March 26, 2019): 31. http://dx.doi.org/10.11606/s1518-8787.2019053000793.

Full text

Abstract:

OBJECTIVE: To analyze the association of characteristics recorded at the time of birth, including weight, occurrence of asphyxia, gestation duration, maternal age and education level, with death from diseases or malformations of the circulatory system in children under 18 years of age. METHODS: The Brazilian Information System on Live Births and Information System on Mortality databases were linked and evaluated following a longitudinal cohort analysis strategy. The following independent variables were evaluated: characteristics recorded at the time of birth, including weight, occurrence of asphyxia, gestation duration, maternal age and education level. Dependent variables were death from diseases or malformations of the circulatory system in children under 18 years of age. Crude relative risks were estimated and relative risks were adjusted for the variables. RESULTS: 6,380 deaths were linked to 4,282,260 birth records, yielding 5,062 pairs considered as true. Low birth weight (RR = 2.26), asphyxia at 1 (RR = 1.72) and 5 minutes (RR = 1.51), prematurity (RR = 1.50), maternal age ≥ 40 years (RR = 2.06), and low maternal education level (RR = 1.45) increased the probability of death caused by circulatory system diseases. In the association with death by malformations of the circulatory system, the predictive variables showed the same association profile, but with greater intensity. CONCLUSIONS: Fetal and maternal factors are associated with increased mortality due to diseases and malformations of the circulatory system. Measures to control these factors and improve access to their diagnosis and treatment would contribute to reducing the number of deaths caused by diseases and malformations of the circulatory system. However, the identification of environmental influences during gestation and birth on the risk of death should be carefully considered due to being influenced by genetic factors.

APA, Harvard, Vancouver, ISO, and other styles

20

Bezerra, Polyana Caroline de Lima, and Gina Torres Rego Monteiro. "Trends in overall mortality and from diseases of the circulatory system in elderly individuals in Rio Branco, Acre, 1980-2012." Revista Brasileira de Geriatria e Gerontologia 21, no. 2 (April 2018): 143–54. http://dx.doi.org/10.1590/1981-22562018021.170128.

Full text

Abstract:

Abstract Objective: To analyze trends in general mortality and circulatory system disease mortality among elderly persons living in the city of Rio Branco, Acre, Brazil, from 1980 to 2012. Method: A study of the cause of death of elderly people was carried out from the data available in the Brazilian Mortality Information System. Crude and age-based overall and circulatory system mortality rates were calculated. The trend analyses of these rates were performed using the JoinPoint Regression program. Results: Despite the reductions in mortality rates, diseases of the circulatory system remained the main cause of death of the elderly in Rio Branco. The decrease in overall mortality rates was higher among elderly women and those aged 70 years or older. There was a tendency for death rates due to diseases of the circulatory system to decline among elderly men and grow among elderly women. Conclusion: The mortality rate among the elderly in Rio Branco revealed a declining trend. Deaths from diseases of the circulatory system were the leading cause of death, suggesting that research should be carried out to assess the need for investment to ensure that increased longevity is accompanied by good quality of life.

APA, Harvard, Vancouver, ISO, and other styles

21

Shudo, Yasuhiro, Rhodalene Benjamin-Addy, Tiffany K. Koyano, William Hiesinger, John W. MacArthur, and Y. Joseph Woo. "Donors after circulatory death heart trial." Future Cardiology 17, no. 1 (January 2021): 11–17. http://dx.doi.org/10.2217/fca-2020-0070.

Full text

Abstract:

Orthotopic heart transplantation is the gold standard treatment for end-stage heart failure. However, the persistent shortage of available donor organs has resulted in an ever-increasing waitlist and longer waiting periods for transplantation. On the contrary, increasing the number of heart transplants by preserving extended criteria donors and donation after circulatory death hearts with the Organ Care System™ (OCS) Heart System has the potential to provide the gold standard, life-saving treatment to patients with end-stage heart failure. The objective of the Donation After Circulatory Death Heart Trial is to evaluate the effectiveness of the OCS Heart System to preserve and assess hearts donated after circulatory death for transplantation to increase the pool of donor hearts available for transplantation, which can potentially provide patients with end-stage heart failure with the life-saving treatment. Clinical Trial Registration: NCT03831048 ( ClinicalTrials.gov )

APA, Harvard, Vancouver, ISO, and other styles

22

Chew, Hong Chee, Mark Connellan, Arjun Iyer, Emily Granger, Christopher Hayward, Andrew Jabbour, Paul Jansz, et al. "Donation after Circulatory Death Heart Transplantation." Transplantation 102 (July 2018): S65. http://dx.doi.org/10.1097/01.tp.0000542638.95876.c9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Dhital, Kumud K., Hong C. Chew, and Peter S. Macdonald. "Donation after circulatory death heart transplantation." Current Opinion in Organ Transplantation 22, no. 3 (June 2017): 189–97. http://dx.doi.org/10.1097/mot.0000000000000419.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Mittal, Shruti, James Gilbert, and Peter J. Friend. "Donors after circulatory death pancreas transplantation." Current Opinion in Organ Transplantation 22, no. 4 (August 2017): 372–76. http://dx.doi.org/10.1097/mot.0000000000000437.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Wall, Stephen P., Carolyn Plunkett, and Arthur Caplan. "Organ Donation After Circulatory Death—Reply." JAMA 314, no. 15 (October 20, 2015): 1646. http://dx.doi.org/10.1001/jama.2015.11444.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Rojas-Peña, Alvaro, Lauren E. Sall, Mark T. Gravel, Elaine G. Cooley, Shawn J. Pelletier, Robert H. Bartlett, and Jeffrey D. Punch. "Donation After Circulatory Determination of Death." Transplantation 98, no. 3 (August 2014): 328–34. http://dx.doi.org/10.1097/tp.0000000000000070.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Morrissey, Paul. "Kidney Donation Before Imminent Circulatory Death." American Journal of Kidney Diseases 68, no. 4 (October 2016): 515–17. http://dx.doi.org/10.1053/j.ajkd.2016.04.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Yadava, Om Prakash. "Donation after circulatory death heart transplant." Indian Journal of Thoracic and Cardiovascular Surgery 36, S2 (August 2020): 297–98. http://dx.doi.org/10.1007/s12055-020-01043-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Iyer, Arjun, Peter Macdonald, Ling Gao, Aoife Doyle, Gayathri Kumarasinghe, Mark Hicks, Paul Jansz, Emily Granger, Phil Spratt, and Kumud Dhital. "Donation after Circulatory Death (DCD) Donors." Heart, Lung and Circulation 25, no. 8 (August 2016): e89-e90. http://dx.doi.org/10.1016/j.hlc.2015.12.012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

SOUZA, DEBORAH C. C., AUGUSTO H. SANTO, and EMILIA I. SATO. "Mortality Profile Related to Systemic Lupus Erythematosus: A Multiple Cause-of-death Analysis." Journal of Rheumatology 39, no. 3 (January 15, 2012): 496–503. http://dx.doi.org/10.3899/jrheum.110241.

Full text

Abstract:

Objective.To analyze the mortality profile related to systemic lupus erythematosus (SLE) in the state of São Paulo, Brazil.Methods.For the 1985–2007 period, we analyzed all death certificates (n = 4815) on which SLE was listed as an underlying (n = 3133) or non-underlying (n = 1682) cause of death. We evaluated sex, age, and the causes of death, comparing the first and last 5 years of the period, as well as determining the observed/expected death ratio (O/E ratio).Results.For SLE as an underlying cause, the mean age at death was 35.77 years (SD 15.12) and the main non-underlying causes of death were renal failure, circulatory system diseases, pneumonia, and septicemia. Over the period, the proportional mention of infectious causes and circulatory system diseases increased, whereas renal diseases decreased. For SLE as a non-underlying cause of death, the most common underlying causes of death were circulatory, respiratory, genitourinary, and digestive system diseases, and certain infections. The overall death O/E ratio was > 1 for renal failure, tuberculosis, septicemia, pneumonia, and digestive system diseases, as well as for circulatory system diseases at < 50 years of age, particularly acute myocardial infarct.Conclusion.Unlike in developed countries, renal failure and infectious diseases are still the most frequent causes of death. The increase in SLE deaths associated with infection, especially pneumonia and septicemia, is worrisome. The judicious use of immunosuppressive therapy together with vigorous treatment of cardiovascular comorbidities is crucial to the successful management of SLE and to improving survival of patients with SLE.

APA, Harvard, Vancouver, ISO, and other styles

31

FLEMING, D. M., K. W. CROSS, and R. S. PANNELL. "Influenza and its relationship to circulatory disorders." Epidemiology and Infection 133, no. 2 (November 30, 2004): 255–62. http://dx.doi.org/10.1017/s0950268804003231.

Full text

Abstract:

Three sources of data (general practice episode data from the Weekly Returns Service of the Royal College of General Practitioners, national hospital admission data for England and national mortality data by date of death) were examined separately in each winter (1994/1995 to 1999/2000) to investigate the impact of influenza on circulatory disease. Weekly data on incidence (clinical new episodes) hospital emergency admissions and deaths certified to circulatory disorders and to respiratory diseases (chapters VII and VIII of ICD9) during influenza epidemic periods (defined from combined clinical/virological surveillance) were examined in age groups 45–64, 65–74 and [ges ]75 years. Data collected in the four winters in which there were substantial influenza A epidemics were consolidated for the period 6 weeks before to 6 weeks after each peak of the epidemic, and associations between the variables at different time lags examined by calculating cross-correlation coefficients. We also examined deaths due to ischaemic heart disease (IHD) as a proportion of all circulatory deaths and deaths due to influenza/pneumonia as a proportion of all respiratory deaths. There were no increases of GP episodes nor of emergency admissions for circulatory disorders in any of the three age groups during epidemic periods. Increased circulatory deaths occurred in all age groups and particularly in the oldest group. The large cross-correlation coefficients of deaths (circulatory and respiratory) with GP respiratory episodes at weekly lags of 0, −1 and 1 were evidence that the deaths and episode distributions were contemporaneous. The ratios of excess circulatory deaths relative to excess respiratory deaths during epidemic periods were 0·74 (age 45–64), 0·72 (65–74) and 0·57 ([ges ]75 years). Increased circulatory deaths contemporary with new incident cases of respiratory episodes but with no concomitant increase in admissions suggests rapid death during the acute phase of illness. Influenza contingency planning needs to take account of these deaths in determining policy for prophylaxis and in providing facilities for cardio-respiratory resuscitation.

APA, Harvard, Vancouver, ISO, and other styles

32

Bozso, Sabin, Vishnu Vasanthan, Jessica GY Luc, Katie Kinaschuk, Darren Freed, and Jayan Nagendran. "Lung Transplantation from Donors after Circulatory Death Using PortableEx VivoLung Perfusion." Canadian Respiratory Journal 22, no. 1 (2015): 47–51. http://dx.doi.org/10.1155/2015/357498.

Full text

Abstract:

BACKGROUND: Donation after circulatory death is a novel method of increasing the number of donor lungs available for transplantation. Using organs from donors after circulatory death has the potential to increase the number of transplants performed.METHODS: Three bilateral lung transplants from donors after circulatory death were performed over a six-month period. Following organ retrieval, all sets of lungs were placed on a portable ex vivo lung perfusion device for evaluation and preservation.RESULTS: Lung function remained stable during portable ex vivo perfusion, with improvement in partial pressure of oxygen/fraction of inspired oxygen ratios. Mechanical ventilation was discontinued within 48 h for each recipient and no patient stayed in the intensive care unit longer than eight days. There was no postgraft dysfunction at 72 h in two of the three recipients. Ninety-day mortality for all recipients was 0% and all maintain excellent forced expiratory volume in 1 s and forced vital capacity values post-transplantation.CONCLUSION: The authors report excellent results with their initial experience using donors after circulatory death after portable ex vivo lung perfusion. It is hoped this will allow for the most efficient use of available donor lungs, leading to more transplants and fewer deaths for potential recipients on wait lists.

APA, Harvard, Vancouver, ISO, and other styles

33

Bolotova, Elena V., Anna V. Kontsevaya, Irina V. Kovrigina, and Larisa P. Lyuberitskaya. "AGE/SEX-SPECIFIC MORTALITY RATES FROM CIRCULATORY SYSTEM DISEASES AMONG OUTPATIENTS OF A KRASNODAR POLYCLINIC." Kuban Scientific Medical Bulletin 26, no. 3 (July 6, 2019): 99–107. http://dx.doi.org/10.25207/1608-6228-2019-26-3-99-107.

Full text

Abstract:

Aim.In this work, we undertook a study of age/sex-specific mortality rates from circulatory system diseases and certain nosological forms in 2015 and 2018 among outpatients of Research Institute — Ochapovsky Regional Clinical Hospital No. 1 delivering primary healthcare services.Materials and methods.We studied age/sex-specific mortality rates from circulatory system diseases among adult population using the data from the medical records of deceased outpatients (Form 025/u), extracts from autopsy reports, as well as medical certificates of death for 2015 and 2018. Non-standardised and standardised mortality rates were calculated.Results.In 2015, all-cause mortality rate by the medical organisation reached 6.2 per 1,000 population, with the total number of deaths from circulatory system diseases amounting to 49.6%. The non-standardised mortality rates from the circulatory system diseases totalled 307.81 per 100,000 population, including the non-standardised mortality rates from cerebrovascular diseases (44.68), ischemic heart disease (129.08) and myocardial infarction (4.96). Standardised mortality rates from circulatory system diseases amounted to 201.96 (men — 70.58, women — 131.38). In 2015, chronic ischemic heart disease (41.94%) ranked first as the cause of mortality among circulatory system diseases followed by diagnoses requiring additional interpretation and examination of primary medical documentation (35.48%), i.e. not clearly defined causes of death; and cerebrovascular diseases (14.52%). In 2018, chronic ischemic heart disease also ranked first (47.54%) followed by cerebrovascular (36.21%) and other diseases (16.39%) (ICD codes I26, I71.1, R00.8).Conclusion.It is shown that more attention from the cardiological and therapeutic services of primary health care is required in coding death-causing circulatory system diseases.

APA, Harvard, Vancouver, ISO, and other styles

34

Le Dinh, Hieu. "Donation after cardio-circulatory death liver transplantation." World Journal of Gastroenterology 18, no. 33 (2012): 4491. http://dx.doi.org/10.3748/wjg.v18.i33.4491.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

IWASAKA, TOSHIJI. "Circulatory organ 1. Sudden death and arrhythmia." Nihon Naika Gakkai Zasshi 89, no. 3 (2000): 524–29. http://dx.doi.org/10.2169/naika.89.524.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Snoeijs, Maarten G., Tineke Wind, and Ernest van Heurn. "Protocols for uncontrolled donation after circulatory death." Lancet 380, no. 9846 (September 2012): 974–75. http://dx.doi.org/10.1016/s0140-6736(12)61533-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Truog, Robert D. "Pediatric Donation After Circulatory Determination of Death." Pediatric Critical Care Medicine 18, no. 11 (November 2017): 1068–70. http://dx.doi.org/10.1097/pcc.0000000000001322.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Weiss, Matthew J., Laura Hornby, William Witteman, and Sam D. Shemie. "Pediatric Donation After Circulatory Determination of Death." Pediatric Critical Care Medicine 17, no. 3 (March 2016): e87-e108. http://dx.doi.org/10.1097/pcc.0000000000000602.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Nakagawa, Thomas A., and Susan L. Bratton. "Pediatric Donation After Circulatory Determination of Death." Pediatric Critical Care Medicine 17, no. 3 (March 2016): 270–71. http://dx.doi.org/10.1097/pcc.0000000000000605.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Cooper, D. K. C. "Transplantation of the Heart After Circulatory Death." American Journal of Transplantation 16, no. 10 (June 14, 2016): 3063. http://dx.doi.org/10.1111/ajt.13864.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Joffe, Ari R. "Organ donation after circulatory determination of death." Critical Care Medicine 40, no. 9 (September 2012): 2718–19. http://dx.doi.org/10.1097/ccm.0b013e31825bc6a9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Beach, Patricia Ringos, Annette M. Hallett, and Kim Zaruca. "Organ Donation After Circulatory Death: Vital Partnerships." AJN, American Journal of Nursing 111, no. 5 (May 2011): 32–38. http://dx.doi.org/10.1097/01.naj.0000398047.85051.ab.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Rodríguez-Arias, David, and Iván Ortega Deballon. "Protocols for uncontrolled donation after circulatory death." Lancet 379, no. 9823 (April 2012): 1275–76. http://dx.doi.org/10.1016/s0140-6736(11)61784-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Cao, Yiming, Sara Shahrestani, Hong Chee Chew, Michael Crawford, Peter Simon Macdonald, Jerome Laurence, Wayne John Hawthorne, Kumud Dhital, and Henry Pleass. "Donation After Circulatory Death for Liver Transplantation." Transplantation 100, no. 7 (July 2016): 1513–24. http://dx.doi.org/10.1097/tp.0000000000001175.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Gardiner, Dale, Tineke Wind, Ben Cole, Walter van Mook, Francisco Del Río, and Beatriz Domínguez-Gil. "European Vignettes in Donation After Circulatory Death." Progress in Transplantation 27, no. 3 (July 4, 2017): 286–90. http://dx.doi.org/10.1177/1526924817715462.

Full text

Abstract:

Donation after circulatory death (DCD) is increasing in Europe, yet there is widespread variability in practice. Insight into actual practice is difficult to acquire simply by analyzing protocols and laws from each individual country. For this reason, the 3 DCD vignettes in this article have been constructed to outline routine and standard DCD practice in the United Kingdom, the Netherlands, and Spain. These imagined vignettes reflect a “typical” case, based on the authors’ extensive experience with DCD but are not real patient cases. They are a resource aimed at stimulating discussion regarding European organ donation practice and provide a knowledge bank for those wanting to establish a DCD program in their country. It is our hope that by providing these vignettes, the wider organ donation and transplant community, as well as philosophers and the public, will have a better understanding of what DCD really is and what it really isn’t.

APA, Harvard, Vancouver, ISO, and other styles

46

Dalle Ave, Anne L., and David M. Shaw. "Controlled Donation After Circulatory Determination of Death." Journal of Intensive Care Medicine 32, no. 3 (July 7, 2016): 179–86. http://dx.doi.org/10.1177/0885066615625628.

Full text

Abstract:

Controlled donation after circulatory determination of death (cDCDD) concerns donation after withdrawal of life-sustaining therapy (W-LST). We examine the ethical issues raised by W-LST in the cDCDD context in the light of a review of cDCDD protocols and the ethical literature. Our analysis confirms that W-LST procedures vary considerably among cDCDD centers and that despite existing recommendations, the conflict of interest in the W-LST decision and process might be difficult to avoid, the process of W-LST might interfere with usual end-of-life care, and there is a risk of hastening death. In order to ensure that the practice of W-LST meets already well-established ethical recommendations, we suggest that W-LST should be managed in the ICU by an ICU physician who has been part of the W-LST decision. Recommending extubation for W-LST, when this is not necessarily the preferred procedure, is inconsistent with the recommendation to follow usual W-LST protocol. As the risk of conflicts of interest in the decision of W-LST and in the process of W-LST exists, this should be acknowledged and disclosed. Finally, when cDCDD programs interfere with W-LST and end-of-life care, this should be transparently disclosed to the family, and specific informed consent is necessary.

APA, Harvard, Vancouver, ISO, and other styles

47

Pagani, Francis D. "Use of Heart Donors Following Circulatory Death." Journal of the American College of Cardiology 73, no. 12 (April 2019): 1460–62. http://dx.doi.org/10.1016/j.jacc.2018.12.068.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Chen, Guodong, Chang Wang, Dicken Shiu-Chung Ko, Jiang Qiu, Xiaopeng Yuan, Ming Han, Changxi Wang, Xiaoshun He, and Lizhong Chen. "Comparison of outcomes of kidney transplantation from donation after brain death, donation after circulatory death, and donation after brain death followed by circulatory death donors." Clinical Transplantation 31, no. 11 (October 15, 2017): e13110. http://dx.doi.org/10.1111/ctr.13110.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Sarkar, Aziza Sultana Rosy, Nurul Islam, and Aminul Hoque. "Cause and age-related mortality trends in Bangladesh (2000-2008)." F1000Research 6 (March 2, 2017): 210. http://dx.doi.org/10.12688/f1000research.10810.1.

Full text

Abstract:

Background The purpose of this study was to analyze mortality trends in Bangladesh from 2000 to 2008, to identify the main causes of death, and categorize them by sex and age group. Methods This study used vital registration, maternal and child health data collected from Matlab, a rural area of Bangladesh, in 2000, 2004 and 2008.The data were collected and published by Health and Demographic Surveillance System of ICDDR, B. Results This study indicates a downward trend in communicable disease, neonatal and maternal, injury and miscellaneous mortality. Only non-communicable diseases (NCDs) revealed an uprising trend for both males and females. Among the NCDs, circulatory system related diseases were most common in Bangladesh. The second major cause of death was neoplasm. The risk of deaths from non-communicable diseases increased with age. The overall death rates were higher for males than females. Males of ages 45 and above were greatly affected by circulatory system related diseases and neoplasm. Circulatory system related deaths were highest (34.01%) in the 70-79 age group. Neoplasm related deaths were highest (34.38%) in the 60-69 age group. Similar patterns were observed for females. Circulatory system related diseases, respiratory related diseases and neoplasms greatly affected females of the 45-59 and above age group. The highest percentage (38.65%) of circulatory system related deaths was found in the 70-79 age group; neoplasm related deaths were highest (29.41%) in the 45-49 age group; and the highest percentage (32.69%) of respiratory related diseases was found in the 60-69 age group. Conclusions It was observed that a large portion of the population died because of non-communicable diseases. Public awareness about common NCDs and the risk factors involved should be raised. Promoting health-related content both in male and female education can bring improvements in reducing NCDs.

APA, Harvard, Vancouver, ISO, and other styles

50

Nowak, Piotr. "Donation After Circulatory Determination of Death. About Precedence of Neurological Criteria of Death over Circulatory Criteria– regulatory issues." Analiza i Egzystencja 42 (2018): 35–53. http://dx.doi.org/10.18276/aie.2018.42-02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Journal articles on the topic 'Circulatory death'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles